Similar Articles
911 Importance of SALL4 in the development and prognosis of hepatocellular carcinoma
912 Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
913 Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
914 Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?
915 Hepatocellular carcinoma: Where are we?
916 Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
917 Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
918 Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art
919 Hepatocellular carcinoma and hepatitis B surface protein
920 Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA